// STATE LEGISLATION TRACKER

Minnesota SF 3615: Health plans requirement to cover infertility treatment and standard fertility preservation services

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: In committee

State: Minnesota
Bill: SF 3615
Session: 2025-2026
Filed: 2026-02-17
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Minnesota SF3615 would require health plans, Medical Assistance, and MinnesotaCare to cover infertility treatment and standard fertility preservation services. Based on the title, subjects, and available status, it does not directly address compounded peptides, off-label prescribing, telehealth, prescriber scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No direct change to peptide access or prescribing rules
Could affect fertility-related medication coverage, but not peptide policy
No apparent impact on compounding pharmacies or 503A/503B rules
No apparent change to NP, naturopathic, or telehealth practice scope

What to Watch For

Note Watch for amendments that add medication limits, prior authorization, or fertility-drug coverage details.

Note If the bill advances, coverage language may become more specific for drugs used in fertility care.

Note No peptide-specific language is visible from the title, subjects, and current bill status.

Where the Bill Stands

The bill was introduced and referred to the Senate Health and Human Services Committee, with the latest listed action adding an author.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws